Matthias Endres

Prof. Dr. med.

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Prof. Dr. med. Matthias Endres is a faculty member at Charité – Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin. His research focuses on the intersections of chronic kidney disease and cognitive impairment, as highlighted in his recent articles exploring biobanks, care pathways, and the effects of chemotherapy on cognitive function. He also investigates the implications of early-life adversity on neuroinflammation and cognitive decline.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (22)

Wolfgang Boehmerle

Charite Universitatsmedizin Berlin Klinik für Neurologie mit Experimenteller Neurologie

GERMANY

Matthias Endres

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia.

CONNECT: what has been done and what needs to be done.

Care pathways for patients with cognitive impairment and chronic kidney disease.

Chemotherapy-related cognitive impairment and kidney dysfunction.

Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors.

Early-Life Adversity Predicts Markers of Aging-Related Neuroinflammation, Neurodegeneration, and Cognitive Impairment in Women.

Effect of IV Thrombolysis With Alteplase in Patients With Vessel Occlusion in the WAKE-UP Trial.

Factors associated with reduction in quality of life after SARS-CoV-2 infection.

Excessive Supraventricular Ectopic Activity in Patients With Acute Ischemic Stroke Is Associated With Atrial Fibrillation Detection Within 24 Months After Stroke: A Predefined Analysis of the MonDAFIS Study.

Cognitive impairment in kidney transplanted patients.

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study

Author Response: Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke: An Analysis of the WAKE-UP Randomized Clinical Trial

Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke

Brain health: Key to health, productivity, and well-being

Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis

Association of White Blood Cell Count With Clinical Outcome Independent of Treatment With Alteplase in Acute Ischemic Stroke

Association of stroke lesion shape with newly detected atrial fibrillation – Results from the MonDAFIS study

Cerebral embolisation during transcatheter edge-to-edge repair of the mitral valve with the MitraClip system: a prospective, observational study

Cerebral small vessel disease burden and cognitive and functional outcomes after stroke: A multicenter prospective cohort study

Combined Oral Triglyceride and Glucose Tolerance Test after Acute Ischemic Stroke to Predict Recurrent Vascular Events: The Berlin "cream&amp;Sugar" Study

Collaborators (22)

Wolfgang Boehmerle

Joji B. Kuramatsu

Joanna Dietzel

Alexander Nave

Jochen B. Fiebach

Malvika Godara

Ivana Galinovic

José M Ferro

Francesco Mattace-Raso

Laura Denby

Maike Stein

Hong Xu

Lauren E. Cipriano

Ralf Mekle

Annette Bruchfeld

Ludwig Schlemm

Lilian Krist

Holger Poppert

Robert Unwin

Abolfazl Avan

Jochen A. Sembill

Sonja Entringer

Make your next move.

Combined Oral Triglyceride and Glucose Tolerance Test after Acute Ischemic Stroke to Predict Recurrent Vascular Events: The Berlin "cream&Sugar" Study